493 related articles for article (PubMed ID: 28652242)
1. Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.
Coates M; Brookes D; Kim YI; Allen H; Fordyce EAF; Meals EA; Colley T; Ciana CL; Parra GF; Sherbukhin V; Stockwell JA; Thomas JC; Hunt SF; Anderson-Dring L; Onions ST; Cass L; Murray PJ; Ito K; Strong P; DeVincenzo JP; Rapeport G
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652242
[TBL] [Abstract][Full Text] [Related]
2. Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium.
Brookes DW; Coates M; Allen H; Daly L; Constant S; Huang S; Hows M; Davis A; Cass L; Ayrton J; Knowles I; Strong P; Rapeport G; Ito K
Br J Pharmacol; 2018 Jun; 175(12):2520-2534. PubMed ID: 29579332
[TBL] [Abstract][Full Text] [Related]
3. Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium.
Mirabelli C; Jaspers M; Boon M; Jorissen M; Koukni M; Bardiot D; Chaltin P; Marchand A; Neyts J; Jochmans D
J Antimicrob Chemother; 2018 Jul; 73(7):1823-1829. PubMed ID: 29596680
[TBL] [Abstract][Full Text] [Related]
4. Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures.
Broadbent L; Parke HG; Ferguson LJ; Millar A; Shields MD; Detalle L; Power UF
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767728
[TBL] [Abstract][Full Text] [Related]
5. Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex.
Cox RM; Toots M; Yoon JJ; Sourimant J; Ludeke B; Fearns R; Bourque E; Patti J; Lee E; Vernachio J; Plemper RK
J Biol Chem; 2018 Oct; 293(43):16761-16777. PubMed ID: 30206124
[TBL] [Abstract][Full Text] [Related]
6. Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus Challenge Study.
DeVincenzo J; Cass L; Murray A; Woodward K; Meals E; Coates M; Daly L; Wheeler V; Mori J; Brindley C; Davis A; McCurdy M; Ito K; Murray B; Strong P; Rapeport G
J Infect Dis; 2022 Jun; 225(12):2087-2096. PubMed ID: 33216113
[TBL] [Abstract][Full Text] [Related]
7. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
Ohol YM; Wang Z; Kemble G; Duke G
PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
[TBL] [Abstract][Full Text] [Related]
8. Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate.
Deval J; Hong J; Wang G; Taylor J; Smith LK; Fung A; Stevens SK; Liu H; Jin Z; Dyatkina N; Prhavc M; Stoycheva AD; Serebryany V; Liu J; Smith DB; Tam Y; Zhang Q; Moore ML; Fearns R; Chanda SM; Blatt LM; Symons JA; Beigelman L
PLoS Pathog; 2015 Jun; 11(6):e1004995. PubMed ID: 26098424
[TBL] [Abstract][Full Text] [Related]
9. Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication
Jorquera PA; Mathew C; Pickens J; Williams C; Luczo JM; Tamir S; Ghildyal R; Tripp RA
J Virol; 2019 Feb; 93(4):. PubMed ID: 30541831
[TBL] [Abstract][Full Text] [Related]
10. Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication.
Lee JS; Lee YN; Lee YT; Hwang HS; Kim KH; Ko EJ; Kim MC; Kang SM
Nutrients; 2015 Feb; 7(2):1021-36. PubMed ID: 25658239
[TBL] [Abstract][Full Text] [Related]
11. Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs.
Salinas FM; Nebreda AD; Vázquez L; Gentilini MV; Marini V; Benedetti M; Nabaes Jodar MS; Viegas M; Shayo C; Bueno CA
Antiviral Res; 2020 Jul; 179():104817. PubMed ID: 32387475
[TBL] [Abstract][Full Text] [Related]
12. Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the Promoter.
Noton SL; Nagendra K; Dunn EF; Mawhorter ME; Yu Q; Fearns R
J Virol; 2015 Aug; 89(15):7786-98. PubMed ID: 25995255
[TBL] [Abstract][Full Text] [Related]
13. Cyclopiazonic acid, an inhibitor of calcium-dependent ATPases with antiviral activity against human respiratory syncytial virus.
Cui R; Wang Y; Wang L; Li G; Lan K; Altmeyer R; Zou G
Antiviral Res; 2016 Aug; 132():38-45. PubMed ID: 27210812
[TBL] [Abstract][Full Text] [Related]
14. The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin.
Kim YI; Pareek R; Murphy R; Harrison L; Farrell E; Cook R; DeVincenzo J
Influenza Other Respir Viruses; 2017 Nov; 11(6):525-530. PubMed ID: 28990339
[TBL] [Abstract][Full Text] [Related]
15. Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine
Mackman RL; Hui HC; Perron M; Murakami E; Palmiotti C; Lee G; Stray K; Zhang L; Goyal B; Chun K; Byun D; Siegel D; Simonovich S; Du Pont V; Pitts J; Babusis D; Vijjapurapu A; Lu X; Kim C; Zhao X; Chan J; Ma B; Lye D; Vandersteen A; Wortman S; Barrett KT; Toteva M; Jordan R; Subramanian R; Bilello JP; Cihlar T
J Med Chem; 2021 Apr; 64(8):5001-5017. PubMed ID: 33835812
[TBL] [Abstract][Full Text] [Related]
16. GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process.
Perron M; Stray K; Kinkade A; Theodore D; Lee G; Eisenberg E; Sangi M; Gilbert BE; Jordan R; Piedra PA; Toms GL; Mackman R; Cihlar T
Antimicrob Agents Chemother; 2015 Dec; 60(3):1264-73. PubMed ID: 26666922
[TBL] [Abstract][Full Text] [Related]
17. Identification and evaluation of a novel tribenzamide derivative as an inhibitor targeting the entry of the respiratory syncytial virus.
Issmail L; Ramsbeck D; Jäger C; Henning T; Kleinschmidt M; Buchholz M; Grunwald T
Antiviral Res; 2023 Mar; 211():105547. PubMed ID: 36682463
[TBL] [Abstract][Full Text] [Related]
18. Respiratory Syncytial Virus-Induced Oxidative Stress Leads to an Increase in Labile Zinc Pools in Lung Epithelial Cells.
Khan NA; Singla M; Samal S; Lodha R; Medigeshi GR
mSphere; 2020 May; 5(3):. PubMed ID: 32461278
[TBL] [Abstract][Full Text] [Related]
19. Characterization of novel respiratory syncytial virus inhibitors identified by high throughput screen.
Laganas VA; Dunn EF; McLaughlin RE; Tiong-Yip CL; Yuzhakov O; Isabella VM; Hill P; Yu Q
Antiviral Res; 2015 Mar; 115():71-4. PubMed ID: 25542974
[TBL] [Abstract][Full Text] [Related]
20. EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model.
Rhodin MHJ; McAllister NV; Castillo J; Noton SL; Fearns R; Kim IJ; Yu J; Blaisdell TP; Panarese J; Shook BC; Or YS; Goodwin B; Lin K
PLoS Pathog; 2021 Mar; 17(3):e1009428. PubMed ID: 33720995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
